Compass Therapeutics, Inc. CMPX
Set alert
0.75 USD -0.01 -1.76%
As of Nov 3, 12:36 PM ET
0.7534 Day range 0.7922
0.73 52-week range 6.88
- YTD
- -85.96%
- 1 year
- -79.84%
- Open
- 0.7833
- Prev close
- 0.7675
- Mkt cap
- 135.80M
- Vol
- 498.32K
- Avg vol
- 4.25M
- EPS
- -0.39
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.7534
- High
- 0.7922
- Forward P/E
- -10.86
- Beta
- 1.30
- Short ratio
- 12.39
- Inst. own
- 88.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.68
- 200-d avg
- 4.58
- 1y target
- 13.64
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 13.64 +1709.4% upside
Now 0.754
- Target (low)
- 8.00
- Target (mean)
- 13.64
- Target (high)
- 30.00
Ratings (0m) 16 16 buy · 0 hold · 0 sell
- Strong buy3
- Buy13
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 16
- 1 month ago 16
- 2 months ago 16
- 3 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.09769 | -0.15 – -0.06 | -0.12 | +18.6% | -600.00K | 0.0% | 13 |
| Next quarter | -0.09615 | -0.12 – -0.06 | -0.14 | +31.3% | 0 | 0.0% | 13 |
| Current year | -0.41077 | -0.62 – -0.17 | -0.42 | +2.2% | 1.14M | 0.0% | 13 |
| Next year | -0.4825 | -1.46 – -0.09 | -0.41077 | -17.5% | 53.31M | +4583.0% | 12 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 24, 2026 | Guggenheim | Reiterated | Buy | Buy |
| Jan 6, 2026 | D. Boral Capital | Maintained | Buy | Buy |
| Jan 5, 2026 | William Blair | Initiated | — | Outperform |
| Dec 3, 2025 | Cantor Fitzgerald | Initiated | — | Overweight |
| Dec 3, 2025 | Citizens | Initiated | — | Market Outperform |
| Dec 3, 2025 | Canaccord Genuity | Initiated | — | Buy |
| Nov 5, 2025 | D. Boral Capital | Maintained | Buy | Buy |
| Oct 6, 2025 | LifeSci Capital | Initiated | — | Outperform |
| Aug 12, 2025 | D. Boral Capital | Maintained | Buy | Buy |
| Aug 12, 2025 | Guggenheim | Maintained | Buy | Buy |
| May 9, 2025 | Guggenheim | Maintained | Buy | Buy |
| Apr 28, 2025 | D. Boral Capital | Maintained | Buy | Buy |
| Apr 22, 2025 | Guggenheim | Reiterated | Buy | Buy |
| Apr 21, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 21, 2025 | D. Boral Capital | Maintained | Buy | Buy |
| Apr 4, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 2, 2025 | Guggenheim | Reiterated | Buy | Buy |
| Apr 2, 2025 | Leerink Partners | Upgrade | Market Perform | Outperform |
| Apr 1, 2025 | D. Boral Capital | Maintained | Buy | Buy |
| Feb 27, 2025 | D. Boral Capital | Maintained | Buy | Buy |
| Feb 25, 2025 | D. Boral Capital | Maintained | Buy | Buy |
| Feb 24, 2025 | Guggenheim | Initiated | — | Buy |
| Feb 19, 2025 | Piper Sandler | Initiated | — | Overweight |
| Feb 10, 2025 | Jefferies | Maintained | Buy | Buy |
| Jan 10, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 8, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jan 8, 2025 | D. Boral Capital | Maintained | Buy | Buy |
| Dec 23, 2024 | D. Boral Capital | Initiated | — | Buy |
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 12, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |